Inventor · disambiguated record
Eliane Piaggio
Also filed as: PIAGGIO ELIANE
14 granted patents·9 pending applications·48 citations·filing 2011–2024
89Inventor score
Files withINST CURIE11INST NAT SANTE RECH MED6CONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET)2KLATZMANN DAVID2CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN CONICET1
Top patents by PatentIndex Score
23 records- 0194US10293028B2Use of low dose IL-2 for treating autoimmune related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2017·Granted May 21, 2019·23 cites·20 claims
- 0288US9669071B2Method for stimulating T lymphocytes with IL-2KLATZMANN DAVID·Filed 2012·Granted Jun 6, 2017·13 cites·18 claims
- 0387US11285176B2Immune cells defective for Suv39h1INST CURIE·Filed 2021·Granted Mar 29, 2022·1 cites·13 claims
- 0487US10765723B2Use of low dose IL-2 for treating autoimmune—related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2019·Granted Sep 8, 2020·5 cites·10 claims
- 0586US12371471B2Immune cells defective for SUV39H1INST CURIE·Filed 2024·Granted Jul 29, 2025·0 cites·16 claims
- 0684US11559566B2Use of low dose IL-2 for treating autoimmune-related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2020·Granted Jan 24, 2023·1 cites·16 claims
- 0782US10576103B2Immune cells defective for SUV39H1INST CURIE·Filed 2019·Granted Mar 3, 2020·3 cites·18 claims
- 0880US11622978B2Immune cells defective for SUV39H1INST CURIE·Filed 2020·Granted Apr 11, 2023·1 cites·23 claims
- 0978US2023201264A1Immune cells defective for suv39h1INST CURIE·Filed 2023·Application pending·0 cites
- 1077US2024216388A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2024·Application pending·0 cites
- 1167US12491232B2Low dose IL-2 for treating autoimmune-related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2023·Granted Dec 9, 2025·0 cites·18 claims
- 1267US9757471B2Protozoan variant-specific surface proteins (VSP) as carriers for oral drug deliveryCONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET)·Filed 2013·Granted Sep 12, 2017·0 cites·16 claims
- 1360US2020157225A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2020·Application pending·0 cites
- 1460US2020147099A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2018·Application pending·0 cites
- 1559US2018228913A1Protozoan variant-specific surface proteins (vsp) as carriers for oral drug deliveryCONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN CONICET·Filed 2017·Application pending·0 cites
- 1656US10183061B2Boosting Treg cells for treating Alzheimer disease and related disordersICM INST DU CERVEAU ET DE LA MOELLE EPINIERE·Filed 2014·Granted Jan 22, 2019·1 cites·56 claims
- 1754US9457096B2Protozoan variant-specific surface proteins (VSP) as carriers for oral drug deliveryCONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET)·Filed 2013·Granted Oct 4, 2016·0 cites·36 claims
- 1853US2024201192A1Folr2+ macrophages and anti-tumor immunityINST CURIE·Filed 2022·Application pending·0 cites
- 1946US2022193198A1Interleukin-2 Variants with Modified Biological ActivityINST CURIE·Filed 2020·Application pending·0 cites
- 2044US2023107291A1Method for Identifying Functional Disease-Specific Regulatory T CellsINST CURIE·Filed 2021·Application pending·0 cites
- 2142US2019056392A1Methods for the diagnostic of an autoimmune diseaseINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 2238US10114018B2IL-2 peptide derivatives, and uses thereof for the diagnosis and treatment of an autoimmune diseaseINST NAT SANTE RECH MED·Filed 2015·Granted Oct 30, 2018·0 cites·4 claims
- 2336US9801927B2Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereofKLATZMANN DAVID·Filed 2011·Granted Oct 31, 2017·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →